risperidone has been researched along with Polydipsia, Primary in 2 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Unger, M | 1 |
| Xiong, G | 1 |
| Rao, N | 1 |
| Venkatasubramanian, G | 1 |
| Korpade, V | 1 |
| Behere, R | 1 |
| Varambally, S | 1 |
| Gangadhar, B | 1 |
2 other studies available for risperidone and Polydipsia, Primary
| Article | Year |
|---|---|
Treatment of refractory psychogenic polydipsia with lithium.
Topics: Antipsychotic Agents; Enzyme Inhibitors; Humans; Hyponatremia; Lithium; Male; Polydipsia, Psychogeni | 2017 |
Risperidone treatment for polydipsia and hyponatremia in schizophrenia: a case report.
Topics: Adult; Antipsychotic Agents; Female; Humans; Hyponatremia; Obesity; Polydipsia, Psychogenic; Risperi | 2011 |